FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Whitepaper

Embedded banking but not as you know it

Admin May 12, 2026 0
Articles

How Smart Money Management and Digital Trends Are Reshaping Wealth in…

Whitepaper

INVESTMENT GUIDE Investing for your future

Whitepaper

5 Approaches to Scaling Finance Accuracy with AI

Whitepaper

Understanding the Financial Interest Clause

Featured News

Empowering Business Transactions in the Modern Economy

Admin Nov 10, 2025
The business-to-business (B2B) payments landscape is undergoing a rapid transformation, with fintech firms driving…
Featured News

Digital Payments Surge as Consumers Embrace Real-Time Transactions and Cardless…

Admin Nov 7, 2025
The fintech industry is experiencing rapid growth as consumers worldwide adopt real-time payments, cardless…
Featured News

Yiren Digital Unveils AI Strategy at Hong Kong Fintech Week

Admin Nov 6, 2025
Yiren Digital Ltd. (NYSE: YRD), a fintech firm specializing in digital consumer lending, insurance, and technology…
Featured News

Global Banks Accelerate Real-Time Payments Adoption as Cross-Border Volume Surges

Admin Nov 5, 2025
Global financial institutions are rapidly expanding real-time payments infrastructure as cross-border transaction…
Featured News

Digital Payments & Embedded Finance: Redefining the Future of Financial…

Admin Nov 4, 2025
The global financial landscape is undergoing a revolution led by digital payments, embedded finance, and…
Featured News

Future of Finance Operations: AI, Automation, and Strategic Leadership

Admin Nov 3, 2025
The financial world is entering a transformative era as organizations shift from traditional bookkeeping and…
Featured News

LoanLynx.ai Launches, Revolutionizing Real Estate Financing

Admin Oct 31, 2025
New York – A significant shift is underway in real-estate lending: the newly launched platform LoanLynx.ai is set…
Whitepaper

Mosaicx Conversational AI for Financial Services

Admin Oct 30, 2025
Improve the patient experience with conversational AI for healthcare. Mosaicx provides insightful and interactive…
Whitepaper

3 Powerful Trends Driving Financial Customer Experience

Admin Oct 29, 2025
Transform Financial Customer Experience with 3 Powerful Trends Customer experience is key to growth and loyalty…
Whitepaper

Climate-Related Financial Risk

Admin Oct 28, 2025
Climate-related financial risk has become a prominent theme that is high on the agenda of U.S. and European…
Featured News

India’s Fintech Renaissance: Opportunity Meets Caution

Admin Oct 27, 2025
India’s fintech industry is at a fascinating crossroads. On one hand, seismic regulatory and infrastructure…
Whitepaper

8 Banking & Financial Services Trends Enterprise Architects Should Know About

Admin Oct 27, 2025
The big banks have not had an easy time of things recently. Already facing plenty of challenges from the likes of…
Featured News

U.S. Markets Rally Strongly as Inflation Eases and Rate-Cut Hopes Grow

Admin Oct 24, 2025
According to reports on October 24, 2025, U.S. stock markets surged on the back of a softer-than-expected…
Featured News

Generative AI Set to Reimagine the Accounting Profession

Admin Oct 20, 2025
In the financial services and accounting domains, generative artificial intelligence is heralding a major shift in…
Featured News

India’s Gold Reserves Cross $100 Billion Mark Amid Global Rally

Admin Oct 17, 2025
October 17, 2025 | Mumbai / New Delhi — In a striking development for India’s external assets, the Reserve…
Whitepaper

The Cyber Resilience Index: Advancing Organizational Cyber Resilience

Admin Oct 15, 2025
The World Economic Forum Centre for Cybersecurity – in collaboration with the Cyber Resilience Index working group…
Banking

Understanding Interest Rates and Their Impact

Admin Oct 14, 2025
Interest rates are one of the most powerful tools that shape the economy, influencing everything from how…
Whitepaper

3 Powerful Trends Driving Financial Customer Experience

Admin Oct 13, 2025
Transform Financial Customer Experience with 3 Powerful Trends Customer experience is key to growth and loyalty…
Featured News

Rising EMI Burden in 2025: Borrowers Struggle as Interest Rates and Living Costs…

Admin Oct 10, 2025
In 2025, millions of Indian borrowers are facing mounting financial pressure as Equated Monthly Installments…
Webinar

India’s Payments & Regulatory Push at Global Fintech Fest 2025

Admin Oct 9, 2025
At the Global Fintech Fest 2025 in Mumbai (Oct 7–9), several major fintech innovations and regulatory moves were…
Featured News

Global Financial Markets Navigate AI Disruption and Economic Tightening

Admin Oct 8, 2025
In 2025, global financial systems are undergoing massive transformation as AI, blockchain, and digital currencies…
Whitepaper

Building a Greenfield Digital Bank in the Fintech Era

Admin Oct 7, 2025
Gone are the days when customers would visit brick and mortar stores 3-5 times a week to complete their daily…
Banking

Banking and the Credit Card System: Fraud or Benefits?

Admin Oct 6, 2025
The banking sector and credit card systems are cornerstones of modern economies. They provide individuals and…
Whitepaper

Choosing a Corporate-to-Bank Integration Model

Admin Oct 3, 2025
Corporate treasurers are creating state-of-the art Treasury organizations to improve the speed and quality of…
Featured News

Finance & Banking Sector

Admin Oct 1, 2025
Indian finance markets are witnessing dynamic shifts as multiple undercurrents converge. One key development: 200…
Featured News

FHLB & First Security Bank Award $30K Grant to Conway Ministry Center

Admin Sep 30, 2025
The Federal Home Loan Bank of Dallas (FHLB Dallas) and First Security Bank have announced a $30,000 grant to the…
Featured News

5 Steps to Banking App Success

Admin Sep 29, 2025
Did you know that nearly three-quarters of all banking interactions now happen through digital channels? A…
Whitepaper

CIO Business Value Guide

Admin Sep 26, 2025
According to BCG, 74% of organizations are struggling to achieve and scale value with AI. Sound familiar? Discover…
Uncategorized

Balancing Control, Cost and Innovation: What’s at Stake When Systems Fall…

Admin Sep 25, 2025
Your roadmap to cost savings, innovation, and operational excellence. Engineering Document Management Systems…
Whitepaper

3 GenAI Use Cases That Immediately Benefit Finance Departments

Admin Sep 24, 2025
Explore how generative AI can transform finance operations. This guide outlines 3 high-impact use cases, including…
Uncategorized

India’s GST 2.0 Reform Sparks Surge in Consumer Spending & Auto Sector Demand

Admin Sep 23, 2025
India’s implementation of the upgraded Goods & Services Tax regime (GST 2.0) has had immediate and tangible…
Featured News

India Slashes GST Rates on Daily Food Items Under GST 2.0: What It Means for…

Admin Sep 22, 2025
India has embarked on one of its most sweeping reforms to the Goods and Services Tax (GST) system, officially…
Previous 1 2 3 4 5 6 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI
    • Understanding the Financial Interest Clause

    ARTICLE

    Candel Therapeutics to Present at Upcoming Investor Conferences
    2026-05-13T12:05:00Z
    NEEDHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) --  Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for...


    Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T12:00:00Z
    WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF),...


    Century Therapeutics Reports First Quarter Financial Results and Business Updates 
    2026-05-13T12:00:00Z
    PHILADELPHIA, May 13, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes,...


    Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
    2026-05-13T12:00:00Z
    Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of excellence


    Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer
    2026-05-13T12:00:00Z
    TAMPA, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Healthmap Solutions (Healthmap), a leading kidney population health management company, has announced the appointment of Jonathan Gavras, MD, FCCP as Chief Medical...


    Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
    2026-05-13T12:00:00Z
    WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin...


    ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
    2026-05-13T12:00:00Z
    MADRID and CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that...


    Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
    2026-05-13T12:00:00Z
    BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of...


    electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
    2026-05-13T12:00:00Z
    ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled,...


    ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
    2026-05-13T12:00:00Z
    PRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today...


    INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
    2026-05-13T12:00:00Z
    Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadership


    Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
    2026-05-13T12:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the...


    Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
    2026-05-13T12:00:00Z
    The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027


    Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
    2026-05-13T12:00:00Z
    Preliminary blinded CR rate for the first 45 subjects in the trial approximates 30% and represents ~67% improvement vs. standard of careFirst 45-subject data unblinding expected before June 30, 2026Program...


    ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
    2026-05-13T12:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better protect against severe allergic reactions...


    Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T12:00:00Z
    BERKELEY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced that chief executive officer Gregory D. Kunst will share...


    Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
    2026-05-13T12:00:00Z
    First-in-human study evaluates weekly IV Sapu003 in advanced mTOR-sensitive solid tumors, including HR+/HER2- breast cancer, RCC, NETs, TSC-associated tumors, and HCC


    InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
    2026-05-13T11:43:28Z
    - Phase 1 trial designed to evaluate the safety, tolerability, and pharmacokinetic properties of ICP-054 (ZB021) in healthy volunteers - Phase 1 SAD and MAD data expected by year-end 2026


    Dyne Therapeutics to Participate in Upcoming Investor Conferences
    2026-05-13T11:30:00Z
    WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today...


    Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T11:30:00Z
    Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna


    Pyxis Oncology to Participate in Upcoming Investor Conferences
    2026-05-13T11:30:00Z
    BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following...


    Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
    2026-05-13T11:30:00Z
    - Three patients treated with ZEVASKYN® in Q1 2026 -


    BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
    2026-05-13T11:30:00Z
    Revenue grew approximately 35% year-over-year to $15.5 million for Q1 2026


    Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
    2026-05-13T11:30:00Z
    Uplisting reflects Palvella’s continued progress advancing potential first-in-disease therapies for serious, rare skin diseases and vascular malformations


    BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
    2026-05-13T11:30:00Z
    PHILADELPHIA and VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies...


    Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
    2026-05-13T11:30:00Z
    Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweight


    Altimmune Announces First Quarter 2026 Financial Results and Business Update
    2026-05-13T11:30:00Z
    Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026


    MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
    2026-05-13T11:30:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced its...


    PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
    2026-05-13T11:30:00Z
    Initiated NDA Submission to the FDA for D-PLEX₁₀₀ ; Completion Expected Imminently


    Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
    2026-05-13T11:25:00Z
    Case study presented highlighted clinical experience with revyve® in complex wound care

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.